Ph.D., Head of Johnson & Johnson Innovation, California
Rowan Chapman is the Head of Johnson & Johnson Innovation, California, a position she assumed in January this year. Before this appointment, Rowan was the Head of Healthcare Investing at GE Ventures, where she led the creation of and sat on the boards of the first three Healthcare “NewCos” incubated and launched from GE Ventures. Prior to that, Rowan served as Head of Precision Diagnostics at GE Healthcare, where she was responsible for strategy development to integrate lab services, products, data, informatics, software, and content. Before GE, she spent 11 years as a Partner at Mohr Davidow Ventures, where she drove development of the life science investment strategy and practice area. Rowan was a very early employee at Rosetta Inpharmatics and a Product Marketing Manager at Incyte Genomics. She holds a Ph.D. and first class honors degree in Biochemistry from Cambridge University, U.K. and was a postdoctoral fellow at the University of California, San Francisco.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: The California Initiative to Advance Precision Medicine is a state-funded effort promoting precision medicine and the impact it has on patient lives, partly through multi-disciplinary, cross-sector demonstration projects. Project leads and other experts will discuss their patient data-based diagnostics and tools, and their vision for broad-ranging improvements to health and healthcare.